Delivery Order SPE2DB24D2105-SPE2DB24FAPBU
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of IMBRUVICA 420 MG TABLET 28S. The $7,322.67 contract has an ultimate completion date of October 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which allows the government to efficiently procure a...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Imbruvica 280 mg tablet. The contract has a ceiling value of $14,645.34 and a performance period through April 26, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,322.67 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp for the supply of IMBRUVICA 420 MG TABLET 28S. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation...
- The Defense Logistics Agency (DLA) awarded a $14,645.34 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division to supply 4565827989 IMBRUVICA 420 MG TABLET 28S. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. Amerisourcebergen,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The contract has a ceiling value of $33,865.10 and a completion date of May 22, 2025. This order is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a $21,968.01 Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is to provide the medication IMBRUVICA 420 MG TABLET 28S, with a completion date of September 3, 2024. This represents a task order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen to supply a comprehensive range of pharmaceutical and medical products to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,575.75 firm fixed-price delivery order is for the supply of IMBRUVICA 280 MG TABLET 28S, a prescription medication. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMBRUVICA 420 MG TABLET 28S. The contract has a ceiling value of $15,151.52 and a completion date of July 29, 2025. The contract is a Firm Fixed Price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide IMBRUVICA 280 MG TABLET 28S. The contract has a potential value of $7,322.67 and a completion date of March 4, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, for the provision of Imbruvica 420 mg tablets. The $14,645.34 firm-fixed-price contract, which has an ultimate completion date of August 2, 2024, was awarded on July 12, 2024 without any set-aside designation. Amerisourcebergen, a subsidiary of the Amerisourcebergen Corporation, holds a significant Indefinite Delivery...
- SPE2DB24D2105Indefinite Delivery Contract
- SPE2DB24D2105-SPE2DB24FAPBUDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division for the provision of IMBRUVICA 420 MG TABLET 28S, a prescription medication. The contract has a ceiling value of $7,322.67 and an ultimate completion date of May 7, 2024. This is not a set-aside contract. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical and medical products to the Department of Defense worldwide. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 4/16/24 |